BR0109455A - Uso de mia e/ou seus fragmentos, método para tratar mamìferos sofrendo de, ou susceptìvel a, uma doença inflamatória, peptìdeo, composição farmacêutica, e, uso dos peptìdeos - Google Patents

Uso de mia e/ou seus fragmentos, método para tratar mamìferos sofrendo de, ou susceptìvel a, uma doença inflamatória, peptìdeo, composição farmacêutica, e, uso dos peptìdeos

Info

Publication number
BR0109455A
BR0109455A BR0109455-6A BR0109455A BR0109455A BR 0109455 A BR0109455 A BR 0109455A BR 0109455 A BR0109455 A BR 0109455A BR 0109455 A BR0109455 A BR 0109455A
Authority
BR
Brazil
Prior art keywords
mia
peptides
fragments
peptide
pharmaceutical composition
Prior art date
Application number
BR0109455-6A
Other languages
English (en)
Inventor
Robert Louis Hubert Nelissen
Gijsbertus Francisc Verheijden
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of BR0109455A publication Critical patent/BR0109455A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0008Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Mycology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

"USO DE MIA E/OU SEUS FRAGMENTOS, MéTODO PARA TRATAR MAMìFEROS SOFRENDO DE, OU SUSCEPTìVEL A, UMA DOENçA INFLAMATóRIA, PEPTìDEO, COMPOSIçãO FARMACêUTICA, E, USO DOS PEPTìDEOS". A invenção refere-se ao uso de MIA para prevenir doenças inflamatórias e, em particular, a seu uso no tratamento de destruição crónica da cartilagem articular. Mais especificamente, MIA pode ser usada para induzir tolerância específica de célula-T ao antígeno MIA em pacientes sofrendo de artrite reumatóide.
BR0109455-6A 2000-03-23 2001-03-15 Uso de mia e/ou seus fragmentos, método para tratar mamìferos sofrendo de, ou susceptìvel a, uma doença inflamatória, peptìdeo, composição farmacêutica, e, uso dos peptìdeos BR0109455A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00201063 2000-03-23
PCT/EP2001/002991 WO2001070253A1 (en) 2000-03-23 2001-03-15 Use of mia in immunotherapy

Publications (1)

Publication Number Publication Date
BR0109455A true BR0109455A (pt) 2003-06-03

Family

ID=8171248

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0109455-6A BR0109455A (pt) 2000-03-23 2001-03-15 Uso de mia e/ou seus fragmentos, método para tratar mamìferos sofrendo de, ou susceptìvel a, uma doença inflamatória, peptìdeo, composição farmacêutica, e, uso dos peptìdeos

Country Status (19)

Country Link
US (1) US20030091583A1 (pt)
EP (1) EP1267907A1 (pt)
JP (1) JP2003527435A (pt)
KR (1) KR20020089404A (pt)
CN (1) CN1418105A (pt)
AR (1) AR027694A1 (pt)
AU (1) AU783170B2 (pt)
BR (1) BR0109455A (pt)
CA (1) CA2399028A1 (pt)
CZ (1) CZ20023187A3 (pt)
HU (1) HUP0300997A2 (pt)
IL (1) IL150679A0 (pt)
MX (1) MXPA02008889A (pt)
NO (1) NO20024458L (pt)
NZ (1) NZ520346A (pt)
PL (1) PL358132A1 (pt)
RU (1) RU2002128351A (pt)
SK (1) SK13692002A3 (pt)
WO (1) WO2001070253A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040076965A1 (en) * 2002-10-16 2004-04-22 Bosserhoff Anja Katrin MIA-2 protein
US8026354B2 (en) * 2005-11-23 2011-09-27 Institut Pasteur Recombinant plasmodium falciparum merozoite surface proteins 4 and 5 and their use
BRPI0706575B8 (pt) * 2006-01-13 2021-05-25 Univ Indiana Res & Tech Corp uso colágeno de tipo v ou um componente antigênico do mesmo, e, método para identificar um paciente em espera de transplante de pulmão para um risco aumentado de rejeição de tecido de órgão transplantado.
EP2307048A4 (en) * 2008-07-16 2012-02-29 Baylor Res Inst HIV VACCINE BASED ON TARGETING OF MAXIMIZED GAG AND NEF ON DENDRITIC CELLS
CN102869679B (zh) * 2010-04-27 2015-11-25 Scil技术股份有限公司 稳定的水性mia/cd-rap制剂
ITRM20110134A1 (it) * 2011-03-22 2012-09-23 Matteo Bordignon Inibitori di mia (attività inibitoria melanoma) per identificare, prevenire e curare la vitiligine
AU2013234815B2 (en) * 2012-03-23 2017-06-22 The University Of Queensland Immunomodulatory agent and uses therefor
ITRM20120339A1 (it) * 2012-07-16 2014-01-17 Matteo Bordignon Uso di mia (attività inibitoria melanoma) per il trattamento della iper-pigmentazione cutanea e per lo sbiancamento cosmetico della pelle
CN116327971A (zh) * 2023-03-02 2023-06-27 暨南大学附属第一医院(广州华侨医院) 一种靶向cd74+促炎型巨噬细胞的药物载体及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE185152T1 (de) * 1993-07-20 1999-10-15 Roche Diagnostics Gmbh Melanom-inhibierendes protein
EP0972022A2 (en) * 1997-01-21 2000-01-19 Human Genome Sciences, Inc. Polynucleotides and polypeptides encoding receptors
DE59810255D1 (de) * 1997-10-16 2004-01-08 Scil Technology Holding Gmbh Nachweis von Knorpelerkrankungen mit MIA

Also Published As

Publication number Publication date
KR20020089404A (ko) 2002-11-29
NZ520346A (en) 2004-07-30
US20030091583A1 (en) 2003-05-15
RU2002128351A (ru) 2004-03-27
AU783170B2 (en) 2005-09-29
AR027694A1 (es) 2003-04-09
MXPA02008889A (es) 2003-04-25
AU4247601A (en) 2001-10-03
HUP0300997A2 (hu) 2003-07-28
PL358132A1 (en) 2004-08-09
JP2003527435A (ja) 2003-09-16
CN1418105A (zh) 2003-05-14
NO20024458D0 (no) 2002-09-18
WO2001070253A1 (en) 2001-09-27
CA2399028A1 (en) 2001-09-27
IL150679A0 (en) 2003-02-12
NO20024458L (no) 2002-09-18
CZ20023187A3 (cs) 2003-01-15
EP1267907A1 (en) 2003-01-02
WO2001070253A8 (en) 2003-03-20
SK13692002A3 (sk) 2003-02-04

Similar Documents

Publication Publication Date Title
Murata et al. Lack of increase in postoperative complications with low-dose methotrexate therapy in patients with rheumatoid arthritis undergoing elective orthopedic surgery
PT942740E (pt) Terapia de combinacao utilizando uma proteina de ligacao de tnf para tratamento de doencas mediadas por tnf
Leipner et al. Therapy with proteolytic enzymes in rheumatic disorders
CY1118849T1 (el) Θεραπεια συνδυασμου για τη θεραπευτικη αγωγη διαταραχων ανεπαρκειας πρωτεϊνης
TR200101205T1 (tr) ímmn hastalìklarìn tedavisi i‡in bir farmas”tik terkip
BR0008276A (pt) Combinações de formoterol e propionato de fluticasona para asma
BR9811556A (pt) Terapia de combinação compreendendo atorvastatina e um agente anti-hipertensivo
BR9807673A (pt) Processos para tratar asma alérgica e dermatite em um humano e composição farmacêutica.
BR9809951A (pt) Método para tratamento da obesidade
BR9811825A (pt) Uso de lactobacillus para redução do nìvel de fibrinogênio no sangue
BR0307508A (pt) Composto, composição farmacêutica, e, métodos de tratamento ou prevenção de dor e inflamação e de tratamento de doença
BR0109455A (pt) Uso de mia e/ou seus fragmentos, método para tratar mamìferos sofrendo de, ou susceptìvel a, uma doença inflamatória, peptìdeo, composição farmacêutica, e, uso dos peptìdeos
PT758241E (pt) Utilizacao de certos derivados de acido metanobisfosfonico para impedir o desprendimento de proteses e a migracao de proteses
ATE293451T1 (de) Behandlung der osteoarthritis durch verabreichung von poly-n-acetyl-d-glucosamin
BR0313239A (pt) Composto, composição farmacêutica, e, métodos de tratamento ou prevenção de dor e inflamação e de doenças
DK0624374T3 (da) Anvendelse af sulodexid og medicin, som indeholder dette, til behandlingen af diabetisk nephropati
PT988043E (pt) Metodo e produto usando notocordio de esturjao para aliviar os sintomas de artrite
SE9603725D0 (sv) New teatment
Tanaka et al. Suppressive effects of hyaluronan on MMP-1 and RANTES production from chondrocytes
BR0012942A (pt) Aplicação de flupirtin para a diminuição de dores em doenças articulares degenerativas de cães e gatos
Stancic-Rokotov et al. Ethanol gastric lesion aggravated by lung injury in rat. Therapy effect of antiulcer agents
BR9812531A (pt) Combinação de componentes, preparação farmacêutica, produção desta, e, uso da combinação ou da preparação farmacêutica
BR9907234A (pt) Polìmeros ligantes de gordura
BR0113646A (pt) Tratamento de distúrbios inflamatórios
BR9808866A (pt) Moléculas retinóicas relacionadas à inibição da superprodução de endotelina-1 em doenças

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE 6A., 7A., E 8A. ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO DA RPI 2016 DE 25/08/2009.